Global Bio-Chem Subsidiary Launches Pilot Testing Platform at Xinglongshan Site
Global Bio-Chem Technology Group Co. Ltd. has announced a strategic cooperation plan involving its subsidiary to establish a pilot testing platform at the Xinglongshan production site. This move aims to support the industrialization of biobased chemicals and medical materials. Despite the suspension of operations at the Xinglongshan site, efforts are underway to introduce new business alliances or investors to resume production. The unveiling ceremony for the pilot testing platform was held successfully, marking a significant step toward transforming technological achievements into industrial outcomes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Bio-Chem Technology Group Co. Ltd. published the original content used to generate this news brief on May 23, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。